Lifetech Scientific (Shenzhen) Co Ltd (Lifetech Shenzhen), a subsidiary of Lifetech Scientific Corp, is a medical device company. It provides invasive interventional medical devices for cardiovascular and peripheral vascular diseases. The company products include dilator, occluders, delivery system, and sizing ballon, among others. It also provides vascular plug system, vena cava filter, stent graft system and snare system. Lifetech Scientific distributes its products through a network of distributors across Europe, North America, South America, Asia and Africa, among others. The company primarily operates in China. Lifetech Shenzhen is headquartered in Shenzhen, China.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Lifetech Scientific (Shenzhen) Co Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Lifetech Scientific (Shenzhen) Co Ltd Company Overview
- Lifetech Scientific (Shenzhen) Co Ltd Company Snapshot
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Lifetech Scientific (Shenzhen) Co Ltd - Pipeline Analysis Overview
- Lifetech Scientific (Shenzhen) Co Ltd - Key Facts
- Lifetech Scientific (Shenzhen) Co Ltd - Major Products and Services
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products by Development Stage
- Lifetech Scientific (Shenzhen) Co Ltd Ongoing Clinical Trials by Trial Status
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products Overview
- FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB)
- FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) Product Overview
- FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) Clinical Trial
- G-Branch Thoracic-Abdominal Aorta Stent Graft System
- G-Branch Thoracic-Abdominal Aorta Stent Graft System Product Overview
- G-Branch Thoracic-Abdominal Aorta Stent Graft System Clinical Trial
- IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
- IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Product Overview
- IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Clinical Trial
- LAmbre LAA Closure System
- LAmbre LAA Closure System Product Overview
- LAmbre LAA Closure System Clinical Trial
- PTCA Drug Eluting Balloon
- PTCA Drug Eluting Balloon Product Overview
- Renal Denervation Catheter
- Renal Denervation Catheter Product Overview
- Lifetech Scientific (Shenzhen) Co Ltd - Key Competitors
- Lifetech Scientific (Shenzhen) Co Ltd - Key Employees
- Lifetech Scientific (Shenzhen) Co Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- Lifetech Scientific (Shenzhen) Co Ltd, Recent Developments
- May 15, 2024: Publication of the One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
- Jul 10, 2023: LifeTech Scientific : Enrollment in the Phase III Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed
- Apr 12, 2023: Publication of the three-year follow-up results of FIM clinical study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
- Dec 13, 2022: Enrollment in the China Randomized Controlled Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed
- Dec 06, 2022: Henry Ford Health to lead first-of-its-kind national trial for innovative heart device
- Sep 05, 2022: FDA-approved investigator-initiated pre-market clinical trial of LAmbre plus LAA closure system obtained medical insurance coverage in the US
- Mar 14, 2022: The first enrollment for confirmatory clinical trials of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System had been completed in China
- Dec 16, 2021: LifeTech and Medtronic further strategic collaboration to open new chapter of domestically-made MRI-Conditional Pacemakers
- Dec 16, 2021: LifeTech and Medtronic further strategic collaboration to open new chapter of domestically-Made MRI-conditional pacemakers
- Nov 30, 2021: Lifetech's first case of the Chinese registered clinical trial (GUARANTEE study) of the Thoracic and Abdominal Aorta Stent Graft System was successfully enrolled
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products by Equipment Type
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products by Indication
- Lifetech Scientific (Shenzhen) Co Ltd Ongoing Clinical Trials by Trial Status
- Lifetech Scientific (Shenzhen) Co Ltd, Key Facts
- Lifetech Scientific (Shenzhen) Co Ltd, Major Products and Services
- Lifetech Scientific (Shenzhen) Co Ltd Number of Pipeline Products by Development Stage
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products Summary by Development Stage
- Lifetech Scientific (Shenzhen) Co Ltd Ongoing Clinical Trials by Trial Status
- Lifetech Scientific (Shenzhen) Co Ltd Ongoing Clinical Trials Summary
- FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Status
- FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Description
- FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Safety and Efficacy Study of FemFlow Drug-eluting Peripheral Balloon Catheter for Lesions with Femoral-popliteal Artery Stenosis or Occlusion: A Prospective, Multi-center, Objective Performance Criteria Clinical Trial
- G-Branch Thoracic-Abdominal Aorta Stent Graft System - Product Status
- G-Branch Thoracic-Abdominal Aorta Stent Graft System - Product Description
- G-Branch Thoracic-Abdominal Aorta Stent Graft System - Guo's Renovisceral Artery Reconstruction-1: A Prospective, Multicenter, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of a Multi-branched Stent Graft System for Thoracoabdominal Aortic Aneurysm (GUARANTEE Study)
- G-Branch Thoracic-Abdominal Aorta Stent Graft System - Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm
- IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System - Product Status
- IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System - Product Description
- IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System - A Prospective, Multi-center, Single-arm Trial of the Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System in Patients with Coronary Artery Disease: IRONMAN-III
- IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System - A Prospective, Multi-center, Single-blinded, Randomized Trial of the Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System in Patients with Coronary Artery Disease: IRONMAN-II
- LAmbre LAA Closure System - Product Status
- LAmbre LAA Closure System - Product Description
- LAmbre LAA Closure System - Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF: The CORRAL-AF Study
- LAmbre LAA Closure System - ESCALLE : Post-marketing Clinical Study of the Lambre System for Left Auricle Closure
- LAmbre LAA Closure System - LAmbre Versus AMPLATZER Amulet Left Atrial Appendage Occluder for Stroke Prophylaxis: The Randomized AMPIRI Trial
- LAmbre LAA Closure System - LifeTech LAmbre Keft Atrial Appendage (LAA) Closure System Post-market Clinical Follow-up
- LAmbre LAA Closure System - Lifetech Lambre Left Atrial Appendage Closure System Post-market Registry Single-center, Single-arm, Prospective, Post-market Registry
- LAmbre LAA Closure System - Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up: MULTI-CENTER, SINGLE-ARM, PROSPECTIVE, POST-MARKET STUDY
- LAmbre LAA Closure System - Safety and Efficacy Study of LAmbre Plus LAA occluder System in Non-valvular Atrial Fibrillation Patients
- PTCA Drug Eluting Balloon - Product Status
- PTCA Drug Eluting Balloon - Product Description
- Renal Denervation Catheter - Product Status
- Renal Denervation Catheter - Product Description
- Lifetech Scientific (Shenzhen) Co Ltd, Key Employees
- Glossary
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products by Equipment Type
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products by Development Stage
- Lifetech Scientific (Shenzhen) Co Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Achieva Medical (Shanghai) Co Ltd
- Anji Hongde Medical Products Co Ltd
- Shunmei Medical Co Ltd
- Beijing Aeonmed Co Ltd
- Beijing Libeier Bio-engineering Institute Co Ltd
